These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9226005)

  • 41. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of HIV infection of resting peripheral blood lymphocytes by nucleosides.
    Watson AJ; Wilburn LM
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1221-7. PubMed ID: 1325818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes: implications for therapy.
    Davis C; Heredia A; Le N; Dominique JK; Redfield RR
    J Hum Virol; 2001; 4(3):113-22. PubMed ID: 11572234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
    Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of HIV replication and macrophage colony-stimulating factor production in human macrophages by antiretroviral agents.
    Kutza J; Fields K; Grimm TA; Clouse KA
    AIDS Res Hum Retroviruses; 2002 Jun; 18(9):619-25. PubMed ID: 12079557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV.
    Lee AW; Mitra D; Laurence J
    AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1235-42. PubMed ID: 9310291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.
    Hartman TL; Yang L; Helfrick AN; Hassink M; Shank NI; George Rosenker K; Scerba MT; Saha M; Hughes E; Wang AQ; Xu X; Gupta P; Buckheit RW; Appella DH
    Antiviral Res; 2016 Oct; 134():216-225. PubMed ID: 27568924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes.
    Düzgünes N; Simões S; Slepushkin V; Pretzer E; Rossi JJ; De Clercq E; Antao VP; Collins ML; de Lima MC
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):515-23. PubMed ID: 11563068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria.
    Morris GW; Laclair DD; McKee EE
    Antivir Ther; 2010; 15(4):587-97. PubMed ID: 20587852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential susceptibility of retroviruses to nucleoside analogues.
    Rosenblum LL; Patton G; Grigg AR; Frater AJ; Cain D; Erlwein O; Hill CL; Clarke JR; McClure MO
    Antivir Chem Chemother; 2001 Mar; 12(2):91-7. PubMed ID: 11527046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages.
    Perno CF; Bergamini A; Pesce CD; Milanese G; Capozzi M; Aquaro S; Thaisrivongs S; Tarpley WG; Zon G; D'Agostini C
    J Infect Dis; 1993 Nov; 168(5):1148-56. PubMed ID: 8228348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors.
    Veal GJ; Agrawal S; Byrn RA
    Antiviral Res; 1998 Apr; 38(1):63-73. PubMed ID: 9614005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An introduction to nucleoside and nucleotide analogues.
    Squires KE
    Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [[ABC of the antivirals] Project Inform].
    Sidahora; 1996; ():19-32. PubMed ID: 11364292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model.
    Fraternale A; Casabianca A; Orlandi C; Cerasi A; Chiarantini L; Brandi G; Magnani M
    Antiviral Res; 2002 Dec; 56(3):263-72. PubMed ID: 12406509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of 3'-halo-5'-norcarbocyclic nucleoside phosphonates as potent anti-HIV agents.
    Hamon N; Kaci M; Uttaro JP; Périgaud C; Mathé C
    Eur J Med Chem; 2018 Apr; 150():642-654. PubMed ID: 29558735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anti-HIV drugs].
    Raffi F
    Rev Prat; 1999 Oct; 49(16):1763-71. PubMed ID: 10578607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphono methoxypropyl)adenine.
    Franchetti P; Rossi L; Cappellacci L; Pasqualini M; Grifantini M; Balestra E; Forbici F; Perno CF; Serafini S; Magnani M
    Antivir Chem Chemother; 2001 May; 12(3):151-9. PubMed ID: 12959323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2002 Sep; 76(18):9143-51. PubMed ID: 12186898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.